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a b s t r a c t
A 54-year-old woman was referred to our institution with frequent chest discomfort and was diagnosed
with drug-refractory paroxysmal atrial ﬁbrillation. Radiofrequency catheter ablation (RFCA) was
performed using a three-dimensional electroanatomic mapping system. After completion of left and
right circumferential pulmonary vein isolation (CPVI), an intravenous bolus of adenosine triphosphate
(ATP, 20 mg) was administered to evaluate the electric reconduction between the pulmonary vein (PV)
and left atrium (LA). Although no PV–LA reconduction was observed, atrial ﬁbrillation (AF) was
reproducibly induced. As the duration of AF was very short (o20 s), no further RFCA to the LA was
performed. One month later, the patient presented with frequent atrial tachyarrhythmias (ATs), and
RFCA was repeated. Although no electric reconduction was observed in the left- or right-sided PVs,
incessant ATs and AF were induced after an intravenous bolus administration of ATP. The earliest atrial
activation site initiating ATs was consistently identiﬁed from electrodes positioned in the superior vena
cava (SVC), and both ATs and AF were no longer inducible after electric isolation of the SVC. ATP-induced
PV/non-PV ectopy may be a marker of increased susceptibility to autonomic triggers of AF and could
potentially predict recurrent AF after CPVI.
& 2015 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.
1. Introduction
Although the pulmonary veins (PVs) represent the predominant
source of atrial ﬁbrillation (AF), non-PV triggers play an important role
in initiating and maintaining AF in approximately 20% of cases [1–3].
Episodes of atrial tachyarrhythmias (ATs) and AF originating from non-
PV triggers are often unpredictable and difﬁcult to identify, owing to
their transient duration and diverse locations. Furthermore, the precise
location may remain unknown, even with the use of a three-
dimensional electroanatomic mapping system (3DEAM).
Several studies have indicated that an intravenous injection of
adenosine, in the form of adenosine triphosphate (ATP), can induce the
transient reconnection of isolated PVs after electric isolation, consistent
with unmasking dormant conduction between the PVs and the left
atrium (LA) [4,5]. Furthermore, ATP, when given as an intravenous
bolus, can induce AF [6]. In addition, several studies have recently
described the usefulness of an ATP injection for inducing and identify-
ing PV and/or non-PV triggers after circumferential pulmonary vein
ablation (CPVI) [7,8]. Here, we describe a case of paroxysmal AF
originating from a non-PV trigger, which was precisely identiﬁed using
ATP infusion and successfully treated using radiofrequency catheter
ablation (RFCA).
2. Case report
A 54-year-old woman was referred to our institution because of
frequent episodes of palpitation and chest discomfort. Although she
was taking several antiarrhythmic drugs, a symptomatic 12-lead
electrocardiogram (ECG) revealed AF, and RFCA was indicated. After
obtaining informed consent from the patient, RFCA was performed
under deep sedation/analgesia using propofol and dexmedetomidine.
Two circular mapping catheters (EPstar Libero, Japan Lifeline Inc.,
Tokyo, Japan) were placed in the superior and inferior PVs, respec-
tively, via a transseptal puncture site, and the left and right-sided
ipsilateral PVs were circumferentially and extensively ablated, using
3DEAM (CARTO, Biosense Webster, Inc., Diamond Bar, CA, USA)
under electrophysiological guidance. After the initial electric isolation
of all 4 PVs, a 20-mg ATP bolus was injected to provoke dormant PV
conduction during coronary sinus pacing. Although no electric
reconduction was observed in the left or right PVs, AF was repro-
ducibly induced (Fig. 1). The duration of AF was very short (o20 s),
and no further AF episodes were observed, even during an
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intravenous drip infusion of isoproterenol (ISP: dosage up to 5 μg/
min), so no further mapping or RFCA was performed, with the
exception of linear ablation at the cavotricuspid isthmus.
However, the patient was later re-admitted with frequent palpi-
tation symptoms similar to those exhibited prior to the initial RFCA.
Despite oral class I antiarrhythmic drug and beta-blocker treatment,
ECG revealed incessant ATs and symptomatic AF (Fig. 2), so repeat
RFCA was performed. Intravenous bolus infusion of ATP did not
produce dormant electrical reconduction in either the left or right
PVs, but incessant AF/ATs were induced. The earliest atrial activation
site initiating incessant AF/ATs was consistently observed from the
electrodes placed between the superior vena cava (SVC) and the
upper right atrium, which was the location identical to that observed
in the initial procedure. To identify the precise ectopic origin, a
circular multielectrode-mapping catheter was positioned superior to
the atriocaval junction within the SVC based on venography. During
R
SP
V
R
IP
V
AP AP
VP
200ms
LS
P
V
LI
P
V
AP
VP VP
AP
(failed)
200ms
AP
Fig. 1. Induction of AF via ATP infusion. Two circular catheters were positioned at both the superior and inferior right (a) and left (b) PVs. The asterisk indicates electrically
dissociated PV potentials. The earliest atrial activation site initiating AF was obtained from the electrodes (black arrow heads) positioned between the HRA and SVC. RSPV,
right superior pulmonary vein; RIPV, right inferior pulmonary vein; LSPV, left superior pulmonary vein; LIPV, left inferior pulmonary vein; AP, atrial pacing; VP, ventricular
pacing; AF, atrial ﬁbrillation; ATP, adenosine triphosphate; PV, pulmonary vein; HRA, upper right atrium; and SVC, superior vena cava.
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Fig. 2. Symptomatic 12-lead and monitoring ECG after initial RFCA. AF/ATs from both 12-lead (upper) and monitoring ECG (lower; black arrows) were incessant during sinus
rhythm (SR). ECG, electrocardiogram; RFCA, radiofrequency catheter ablation; AF, atrial ﬁbrillation; and AT, atrial tachyarrhythmias.
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Fig. 3. Initiation of AF and subsequent ATs after ATP infusion. (a) After ATP bolus infusion, AF was initiated via the earliest atrial activation site observed from the electrodes
(black arrow heads) located between the HRA and SVC, identical in location to the initial procedure. (b) Incessant ATs (black arrows) were induced via the earliest atrial
activation site (black arrow heads), consistent with AF initiation. (c) Note the spiky potentials (black arrow heads), which were observed from the circular mapping catheter
(described as “Lasso” in ﬁgure) positioned at the SVC, above the atriocaval junction. These potentials preceded the atrial electrograms during incessant ATs. LSPV, left
superior pulmonary vein; LIPV, left inferior pulmonary vein; HBE, His bundle electrogram; AP, atrial pacing; SR, sinus rhythm; AF, atrial ﬁbrillation; AT, atrial
tachyarrhythmias; ATP, adenosine triphosphate; HRA, upper right atrium; ans SVC, superior vena cava.
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repetitive ATs, the activation recorded from the mapping catheter
was consistently the earliest, and AT was diagnosed as being triggered
by a non-PV focus within the SVC (Fig. 3). Electric isolation of the SVC
was therefore performed (Fig. 4), after which AF/ATs were no longer
inducible. Only dissociated potentials from the mapping catheter in
the SVC were observed, despite repeated ATP bolus injections with
and without concomitant ISP infusion. The patient did not exhibit any
AF/ATs during a follow-up period of approximately 6 months.
3. Discussion
Adenosine is known to hyperpolarize atria cells via activation of the
A1 adenosine receptor-mediated inwardly rectifying potassium cur-
rents (IKAdo), which shorten the action potential duration (APD) and the
effective refractory period [9]. While established, the mechanisms
behind the association of these ionic interactions, adenosine-induced
PV (and/or non-PV) trigger activation, and clinical AF remain unclear.
Several reports have indicated that adenosine (in the form of
ATP) can generate autonomic activation of PV triggers. Cheung et al.
[10] presumed that adenosine-induced PV triggers were in part
elicited by activation of parasympathetic triggers because adenosine
and acetylcholine (ACh), both of which are parasympathetic neuro-
transmitters with cardiac stimulatory actions, act on identical cell
signaling pathways to produce signiﬁcant antiadrenergic effects
[11]. Adenosine and ACh share similar G-protein receptor-effector
coupling systems (class A18 rhodopsin-like; adenosine interacts
with the A1 receptor, and ACh with muscarinic [M2] receptor).
Activation of these systems generates the outward potassium
currents IKAdo and M2 receptor-mediated inwardly rectifying potas-
sium currents, respectively, resulting in hyperpolarization of the
cardiac cell membrane and shortening of the atrial APD and
refractory period. Such ionic interactions would provide a favorable
substrate for atrial arrhythmogenic activities such as AF/ATs.
With respect to ACh, several reports have described the relevance
between the ACh-mediated cholinergic effect, which stimulates the
intrinsic cardiac autonomic nervous system (ICANS), and PV and/or
non-PV triggers. In dogs, administration of ACh into the ganglionated
plexi (GP) fat pad, a major ICANS situated at the PV–LA junction,
induced spontaneous PV triggers and AF [12]. In addition, Lu et al.
[13] demonstrated that the hyperactivity of the SVC-aorta-GP axis,
another major ICANS, induced by direct injection of ACh could lead to
rapid ﬁring from the SVC. Under the existence of both efferent
parasympathetic and sympathetic neurons in the GPs, stimulation of
these major ICANSs would sympathetically produce a high cytosolic
Ca2þ enhanced by calcium transients and parasympathetically
induce APD shortening. Subsequently, enhanced intracellular Ca2þ
accumulation occurs at membrane voltages negative to the equili-
brium potential for the sodium–calcium exchanger (NCX) due to
enhanced repolarization, which acts as its forward mode resulting in
an inward current, leading to generation of an early after depolariza-
tion (EAD), and re-excitation of the myocardium, causing PV and/or
non-PV ﬁring [14].
Considering the fact that both ATP and ACh share G-protein
mediated autonomic effects, ATP-induced PV and/or non-PV ﬁring
may be partly due to stimulation of the GP, as is observed with
ACh administration.
On the other hand, several authors reported that an ATP bolus
injection could promote signiﬁcant sympathomimetic effects.
Biaggioni et al. suggested that intravenous ATP administration
primarily activates afferent nerves via arterial (or carotid body)
chemoreceptors or baroreceptors resulting in sympathetic activa-
tion [15]. This increase in sympathetic tone is frequently followed
by an abrupt shift toward vagal predominance, which may facil-
itate the induction of AF from the arrhythmogenic site [16,17].
Therefore, the ATP-induced non-PV trigger originating within the
SVC in the present case might have been elicited by both sympathetic
and parasympathetic activity. The suggested mechanism is the partial
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Fig. 4. Intracardiac recordings and catheter position during electric SVC isolation. (a) The spiky potentials (asterisk) from the circular mapping catheter (described as “Lasso”
in ﬁgure), located above the atriocaval junction guided by SVC venography, disappeared during RF energy application. (b, c) Yellow arrow heads indicate the presumed
earliest atrial activation site before circular catheter positioning. Venography was performed via the 2 long sheaths and a circular mapping catheter was inserted through one
of these long sheaths, positioned above the presumed earliest atrial activation site. Note the RFCA sites (yellow dots) in the lower part than the circular catheter position
guided by 3DEAM (Ensite-NavX). CS, coronary sinus; HBE, His bundle electrogram; HRA, upper right atrium; RAO, right anterior oblique; SVC, superior vena cava; RF,
radiofrequency; and RFCA, radiofrequency catheter ablation.
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stimulation of the SVC-aorta-GP axis via G-protein signaling that
hyperactivates Ca2þ transient leading to an inward current via the
NCX during APD shortening, which subsequently generates a trig-
gered EAD leading to non-PV ﬁring.
The major concern of ATP administration is whether these
triggers could be induced reproducibly and whether they could be
induced from the same source. This issue remains controversial
and to our knowledge, relevant systematic studies have not been
reported. The lack of reproducible arrhythmogenic activity from
the same source may limit the accuracy of 3DEAM, making its
precise identiﬁcation difﬁcult. In the present case, incessant AF/
ATs originating from the SVC were reproducibly induced by ATP
infusion. Given the above-mentioned concerns, however, we
performed electric SVC isolation, rather than focal trigger ablation,
which is essential for identifying the exact trigger source.
The ability of ISP to provoke PV-/non-PV foci when adminis-
tered by an intravenous drip infusion with an incremental dosage
(1–2 μg/min, increasing up to 20 μg/min) is widely recognized [18].
However, both the onset of action and the decline in activity are
delayed. This requires high doses and a continuous infusion for at
least 15 min to override the sedation effect and simultaneously
produce physiologic catecholamine discharge as previously pro-
posed [7], which limits the clinical usefulness of the drug. In the
present case, the maximum ISP dosage during the initial proce-
dure was 5 μg/min, which was discontinued because of hemody-
namic instability; therefore, the sedation effect could not be
negated, limiting the provocation of the non-PV trigger.
To eradicate ATP- or ISP-mediated concerns, Zhang et al. have
recently demonstrated the effectiveness of using ATP in combina-
tion with ISP infusion for unmasking non-PV triggers [19]. In their
study, among 39 patients in whom ATP reproducibly induced AF,
only 5 μg/min of ISP was used before the administration of ATP,
which was comparable to the present case. This approach, used to
increase the heart rate by E20 bpm from baseline, was designed
to elicit an obvious change in autonomic tone, leading to higher
reproducibility and longer durability of ATP-induced non-PV
triggers [5,20]. As a result, none of the patients showed AF
originating from a non-PV trigger during ISP infusion alone, with
AF only revealed by additional ATP injection. The ﬁndings from
this case indicate that ATP administration could be useful when
the optimal ISP dosage cannot be tolerated. Furthermore, to
achieve higher reproducibility and longer durability of ATP-
induced non-PV triggers, the combination of ATP and ISP, might
be more effective for unmasking than either drug alone, although
further investigation is needed to conﬁrm the combined effect by
these drugs.
In conclusion, ATP-induced AF after CPVI is strongly associated
with spontaneous AF via non-PV triggers, as described in the
present case. ATP injection may be useful for identifying ﬁbrilla-
tory arrhythmogenic sites.
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